Tenet Healthcare (NYSE:THC) Given Buy Rating at Mizuho

Mizuho reissued their buy rating on shares of Tenet Healthcare (NYSE:THC – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $130.00 price target on the stock, up from their previous price target of $118.00. A number of other analysts also recently weighed in on THC. Stephens increased their […]

Related Keywords

United States ,Richardj Mark ,Paolam Arbour , ,Sunbelt Securities Inc ,Rise Advisors ,Fintrust Capital Advisors ,Cantor Fitzgerald ,Securities Exchange Commission ,Tenet Healthcare Corporation ,Tenet Healthcare Company Profile ,Tenet Healthcare ,Barclays ,Free Report ,Truist Financial ,Get Free Report ,Exchange Commission ,Director Richard ,Trust Capital Advisors ,United States Financial Formulas ,Healthcare Corporation ,Hospital Operations ,Tenet Healthcare Daily ,Nyse Thc ,Thc ,Medical ,88033g40 ,Reiterated Rating ,Mizuho ,